Biodexa Pharmaceuticals (BDRX) - Tingkat bathi reged

Simbol resmi perusahaan biodexapharma.com (BDRX)

The current gross margin level of Biodexa Pharmaceuticals (BDRX), which develops unique drug delivery methods for brain oncology, demonstrates financial momentum. The value of 0.00 shows the latest figure for this metric. A stable authority in the biotech sector is complemented by a risk mitigation strategy via targeted chemotherapy, which minimizes toxic impact on the patient's body.

Biodexa Pharma - Margin reged BDRX (periode 28.04.2023 - 20.11.2026)

Rincian analitis lan laporan data perusahaan Biodexa Pharma (BDRX)

- nilai pasar lan prakiraan target analis:
Analisis dhasar perusahaan:BDRX, Biodexa Pharmaceuticals
Produk asil prodhuksi Biodexa

Gross margin measures production efficiency by determining the profit share after deducting direct costs of product creation. Analyzing the gross margin ratio allows for an assessment of a business's ability to generate cash flow to cover operating expenses and investments. For Biodexa Pharmaceuticals (BDRX), this metric confirms the high added value of orphan drugs, providing pricing power within the narrow neuro-oncology segment.